Table 2.
Intra-organ distribution and pathological stage of thyroid carcinomas with and without coexisting HT (MF = multifocal, UF = unifocal)
| HT + TC | TC without HT | p value | |
|---|---|---|---|
| Multifocality | |||
| • PTC | |||
| - MF/ all PTC cases (%) | 16/40 (40.0%) | 45/190 (23.7%) | |
| - UF/ all PTC cases (%) | 24/40 (60.0%) | 145/190 (76.3%) | 0.034 |
| • FTC | |||
| - MF/ all FTC cases (%) | 0/3 (0.0%) | 4/15 (26.7%) | |
| - UF/ all FTC cases (%) | 3/3 (100.0%) | 11/15 (73.3%) | ns |
| pT tumor stage | |||
| • PTC | 1.33 ± 0.73 | 1.48 ± 0.76 | ns |
| • FTC | 1.33 ± 0.58 | 1.92 ± 1.19 | ns |
| pN lymph node status | |||
| • PTC | |||
| - pN1/ all PTC cases | 4/11 (34.6%) | 34/41 (82.9%) | |
| - pN0/ all PTC cases | 7/11 (65.4%) | 7/41 (17.0%) | 0.002 |
| • FTC | |||
| - pN1/ all FTC cases | 0/1 (0.0%) | 1/1 (100.0%) | |
| - pN0/ all FTC cases | 1/1 (100.0%) | 0/1 (0.0%) | ns |
| TNM stage | |||
| • PTC cases | 1.20 ± 0.61 | 1.33 ± 0.79 | ns |
| • FTC cases | 1.00 ± 0 | 1.69 ± 1.18 | ns |